I Love Lund (LOVE) Q1 2025 earnings summary

Executive summary

• Focus on local investments in innovative Lund-based companies, with a diversified portfolio across sectors and a strong emphasis on sustainability and community engagement.

• Q1 2025 marked by a negative result, mainly due to a one-time accounting change and selective write-downs, not operational underperformance.

• New investments in Avidicare AB and a convertible loan in Alixlabs AB; fewer but larger transactions this quarter.

• High shareholder engagement, with a record turnout at the annual meeting and new board member Mats Lind.

Financial highlights

• Net sales: SEK 0 (unchanged year-over-year); other operating income SEK 6,975 (13,950).

• Operating income: SEK -751,000 (Q1 2024: -686,000).

• Net result after financial items: SEK -4.2 million (Q1 2024: -2.0 million), mainly due to SEK -2.9 million one-off from valuation change.

• Earnings per share: SEK -9.83 (Q1 2024: -5.28).

• Equity per share: SEK 83.16 (Q1 2024: 109.2); NAV per share: SEK 104.39.

• Solidity: 98.6%.

• Cash at period end: SEK 1.46 million.

Outlook and guidance

• A major investment in a local life science company is imminent post-period.

• No formal forecasts provided.